Bill & Melinda Gates Foundation Vaccine Empire on Trial in India

While fraud and corruption are revealed on almost a daily basis now in the vaccine industry, the U.S. mainstream media continues to largely ignore such stories. Outside the U.S., however, the vaccine empires are beginning to crumble, and English versions of the news in mainstream media outlets are available via the Internet.

One such country is India, where the Bill & Melinda Gates Foundation and their vaccine empire are under fire, including a pending lawsuit currently being investigated by the India Supreme Court. Narayana Kumar of The Economic Times of India has just written a scathing report of fraud and scandals surrounding the Gates vaccine empire: Controversial vaccine studies: Why is Bill & Melinda Gates Foundation under fire from critics in India?

Kumar starts out his 4 page article by focusing on the current case before the India Supreme Court regarding deaths and injuries occurring during drug trials carried out over Merck’s HPV vaccine Gardasil. Vaccine trials were conducted on thousands of girls between the ages of 9 and 15. Many of the girls fell ill, and at least 7 died, and the lawsuit is alleging that in most of these cases, the girls and their parents did not even know what kind of vaccine trial they were participating in.

Most of the girls were students, and an investigation showed that as many as 120 girls who participated in the HPV vaccine trials “experienced adverse reactions such as epileptic seizures, severe stomach ache, headaches and mood swings. The Sama report also said there had been cases of early onset of menstruation following the vaccination, heavy bleeding and severe menstrual cramps among many students.”

Kumar points out that after these adverse reactions, a report was conducted to explain them all away as not related to the vaccines, so that the approval process could move forward to market the HPV vaccine in India. That report, according to Kumar, was funded by the Bill & Melinda Gates Foundation (BMGF). Authorities in India have looked into BMGF, and see a huge conflict of interest:

Activists allege that these two institutions have a working relationship with pharma companies. The main charge against GAVI is that it has representatives from pharmaceutical companies on its board while the PHFI accepts grants from pharma companies. “BMGF and GAVI are pushing the [vaccine] agenda with governments around the world, including India,” says Ritu Priya Mehrotra, professor of Social Medicine and Community Health and School of Social Sciences, Jawaharlal Nehru University, Delhi. The community health activist says the biotechnology industry was pushing more and more vaccines into India and that the health ministry was not ensuring that adequate testing was done before recommending their use in government programmes. (Source.)

GAVI is an organization started in 2000 and funded by BMGF. In short, they work together with the World Health Organization (WHO), specifically UNICEF, to purchase vaccines from pharmaceutical companies for distribution in poorer countries. The Gates basically help poorer countries buy more vaccines, which in turn increases the markets of the vaccine manufacturers among poorer people who would not normally be able to afford them. WHO is the largest purchaser of vaccines in the world, but member country contributions via tax revenues often fall short of the volume of vaccines they wish to purchase and distribute, so BMGF stepped in to help form GAVI to make up the difference. Kumar reports:

The GAVI board comprises of a representative each of the pharma industry from the industrialized and developing countries, a sore point with some experts from the aid world. In an article in the The Guardian three years ago, leaders of international aid agencies such as Oxfam and MSF said the representatives of companies needed to step down from the GAVI board. “Pharmaceutical companies’ representation on GAVI’s board creates a conflict of interest. The current structure is far too cosy,” said the article quoting Mohga Kamal-Yanni, a senior policy adviser with Oxfam. (Source.)

Kumar then moves on from the HPV vaccine scandal and writes about the deaths of many infants soon after they were immunized with the Pentavalent vaccine, a five-in-one shot, which was promoted by BMGF and GAVI, even after the deaths were revealed. (Health Impact News previously reported this story here.) Kumar reports:

In an opinion piece published recently in Deccan Herald titled “New Vaccines: Gates Foundation’s philanthropy or business?”, Dr Gopal Dabade of the All India Drug Action Network said that GAVI had committed a $165-million grant for the phased introduction of Pentavalent in India and provides a subsidy of Rs 145 per injection for five years after which the government will have to pay the total cost of the vaccines. “BMGF is a founding partner of GAVI. Its initial grant helped establish GAVI and it continues to support its work. Some of the pharmaceutical companies have affiliation with BMGF to manufacture the vaccine,” Dr Dabade said.

Unlike the U.S., victims of vaccine harm and fraud will get their day in court as the Supreme Court in India takes up the HPV Gardasil fraud claims. Also unlike the U.S., investigative reporters like Narayana Kumar are doing their job and publishing their findings in the mainstream media, informing the public.

Source: